These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

519 related items for PubMed ID: 18266834

  • 1. Serum levels of Th2 chemokines, CCL17, CCL22, and CCL27, were the important markers of severity in infantile atopic dermatitis.
    Nakazato J, Kishida M, Kuroiwa R, Fujiwara J, Shimoda M, Shinomiya N.
    Pediatr Allergy Immunol; 2008 Nov; 19(7):605-13. PubMed ID: 18266834
    [Abstract] [Full Text] [Related]

  • 2. Serum measurement of thymus and activation-regulated chemokine/CCL17 in children with atopic dermatitis: elevated normal levels in infancy and age-specific analysis in atopic dermatitis.
    Fujisawa T, Nagao M, Hiraguchi Y, Katsumata H, Nishimori H, Iguchi K, Kato Y, Higashiura M, Ogawauchi I, Tamaki K.
    Pediatr Allergy Immunol; 2009 Nov; 20(7):633-41. PubMed ID: 19236603
    [Abstract] [Full Text] [Related]

  • 3. Effect of an antiallergic drug (Olopatadine hydrochloride) on TARC/CCL17 and MDC/CCL22 production by PBMCs from patients with atopic dermatitis.
    Furukawa H, Takahashi M, Nakamura K, Kaneko F.
    J Dermatol Sci; 2004 Dec; 36(3):165-72. PubMed ID: 15541638
    [Abstract] [Full Text] [Related]

  • 4. Serum levels of cutaneous T-cell attracting chemokine (CTACK) as a laboratory marker of the severity of atopic dermatitis in children.
    Hon KL, Leung TF, Ma KC, Li AM, Wong Y, Fok TF.
    Clin Exp Dermatol; 2004 May; 29(3):293-6. PubMed ID: 15115514
    [Abstract] [Full Text] [Related]

  • 5. Both Th2 and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis.
    Shimada Y, Takehara K, Sato S.
    J Dermatol Sci; 2004 May; 34(3):201-8. PubMed ID: 15113590
    [Abstract] [Full Text] [Related]

  • 6. CC chemokines as potential immunologic markers correlated with clinical improvement of atopic dermatitis patients by immunotherapy.
    Kwon YS, Oh SH, Wu WH, Bae BG, Lee HJ, Lee MG, Lee KH.
    Exp Dermatol; 2010 Mar; 19(3):246-51. PubMed ID: 19758316
    [Abstract] [Full Text] [Related]

  • 7. Are age-specific high serum IgE levels associated with worse symptomatology in children with atopic dermatitis?
    Hon KL, Lam MC, Leung TF, Wong KY, Chow CM, Fok TF, Ng PC.
    Int J Dermatol; 2007 Dec; 46(12):1258-62. PubMed ID: 18173519
    [Abstract] [Full Text] [Related]

  • 8. Macrophage-derived chemokine (MDC)/CCL22 produced by monocyte derived dendritic cells reflects the disease activity in patients with atopic dermatitis.
    Hashimoto S, Nakamura K, Oyama N, Kaneko F, Tsunemi Y, Saeki H, Tamaki K.
    J Dermatol Sci; 2006 Nov; 44(2):93-9. PubMed ID: 17008059
    [Abstract] [Full Text] [Related]

  • 9. Serum concentrations of CCR4 ligands in relation to clinical severity of atopic dermatitis in Egyptian children.
    Mostafa GA, Tomoum HY, Salem SA, Abd El-Aziz MM, Abou El-Maged DI, El-Sayed El-Far I.
    Pediatr Allergy Immunol; 2008 Dec; 19(8):756-62. PubMed ID: 18435706
    [Abstract] [Full Text] [Related]

  • 10. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis.
    Hijnen D, De Bruin-Weller M, Oosting B, Lebre C, De Jong E, Bruijnzeel-Koomen C, Knol E.
    J Allergy Clin Immunol; 2004 Feb; 113(2):334-40. PubMed ID: 14767451
    [Abstract] [Full Text] [Related]

  • 11. Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis.
    Jahnz-Rozyk K, Targowski T, Paluchowska E, Owczarek W, Kucharczyk A.
    Allergy; 2005 May; 60(5):685-8. PubMed ID: 15813816
    [Abstract] [Full Text] [Related]

  • 12. Significance of interleukin-16, macrophage-derived chemokine, eosinophil cationic protein and soluble E-selectin in reflecting disease activity of atopic dermatitis--from laboratory parameters to clinical scores.
    Angelova-Fischer I, Hipler UC, Bauer A, Fluhr JW, Tsankov N, Fischer TW, Elsner P.
    Br J Dermatol; 2006 Jun; 154(6):1112-7. PubMed ID: 16704642
    [Abstract] [Full Text] [Related]

  • 13. TARC augments TNF-alpha-induced CTACK production in keratinocytes.
    Vestergaard C, Johansen C, Christensen U, Just H, Hohwy T, Deleuran M.
    Exp Dermatol; 2004 Sep; 13(9):551-7. PubMed ID: 15335355
    [Abstract] [Full Text] [Related]

  • 14. Increased serum thymus and activation-regulated chemokine and cutaneous T cell-attracting chemokine levels in children with atopic dermatitis.
    Song TW, Sohn MH, Kim ES, Kim KW, Kim KE.
    Clin Exp Allergy; 2006 Mar; 36(3):346-51. PubMed ID: 16499646
    [Abstract] [Full Text] [Related]

  • 15. Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22.
    Niens M, Visser L, Nolte IM, van der Steege G, Diepstra A, Cordano P, Jarrett RF, Te Meerman GJ, Poppema S, van den Berg A.
    Br J Haematol; 2008 Mar; 140(5):527-36. PubMed ID: 18275430
    [Abstract] [Full Text] [Related]

  • 16. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity.
    Kakinuma T, Nakamura K, Wakugawa M, Mitsui H, Tada Y, Saeki H, Torii H, Asahina A, Onai N, Matsushima K, Tamaki K.
    J Allergy Clin Immunol; 2001 Mar; 107(3):535-41. PubMed ID: 11240957
    [Abstract] [Full Text] [Related]

  • 17. Aberrant Expression of Bacterial Pattern Recognition Receptor NOD2 of Basophils and Microbicidal Peptides in Atopic Dermatitis.
    Wong CK, Chu IM, Hon KL, Tsang MS, Lam CW.
    Molecules; 2016 Apr 11; 21(4):471. PubMed ID: 27077833
    [Abstract] [Full Text] [Related]

  • 18. Serum mucosa-associated epithelial chemokine (MEC/CCL28) in atopic dermatitis: a specific marker for severity.
    Ezzat MH, Sallam MA, Shaheen KY.
    Int J Dermatol; 2009 Aug 11; 48(8):822-9. PubMed ID: 19659860
    [Abstract] [Full Text] [Related]

  • 19. Chemokine levels in serum of children with atopic dermatitis with regard to severity and sensitization status.
    Ahrens B, Schulz G, Bellach J, Niggemann B, Beyer K.
    Pediatr Allergy Immunol; 2015 Nov 11; 26(7):634-40. PubMed ID: 26102348
    [Abstract] [Full Text] [Related]

  • 20. Inhibitory effect of 5,6-dihydroergosteol-glucoside on atopic dermatitis-like skin lesions via suppression of NF-κB and STAT activation.
    Jung M, Lee TH, Oh HJ, Kim H, Son Y, Lee EH, Kim J.
    J Dermatol Sci; 2015 Sep 11; 79(3):252-61. PubMed ID: 26100037
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.